0001493152-24-033344.txt : 20240820
0001493152-24-033344.hdr.sgml : 20240820
20240820210114
ACCESSION NUMBER: 0001493152-24-033344
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240815
FILED AS OF DATE: 20240820
DATE AS OF CHANGE: 20240820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CURHAN GREGORY S
CENTRAL INDEX KEY: 0001263244
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38519
FILM NUMBER: 241226985
MAIL ADDRESS:
STREET 1: 600 CALIFORNIA STREET, 9TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Serina Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 821436829
STATE OF INCORPORATION: AL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GENOME WAY
STREET 2: SUITE 2001
CITY: HUNTSVILLE
STATE: AL
ZIP: 35806
BUSINESS PHONE: (256) 327-9630
MAIL ADDRESS:
STREET 1: 601 GENOME WAY
STREET 2: SUITE 2001
CITY: HUNTSVILLE
STATE: AL
ZIP: 35806
FORMER COMPANY:
FORMER CONFORMED NAME: AgeX Therapeutics, Inc.
DATE OF NAME CHANGE: 20170606
4
1
ownership.xml
X0508
4
2024-08-15
0
0001708599
Serina Therapeutics, Inc.
SER
0001263244
CURHAN GREGORY S
601 GENOME WAY, SUITE 2001
HUNTSVILLE
AL
35806
0
1
0
0
Chief Financial Officer
0
Stock Option (right to buy)
6.66
2024-08-15
4
A
0
250000
0
A
2024-08-15
Common Stock
250000
250000
D
The stock options vest in substantially equal monthly installments beginning on September 15, 2024 such that the stock options shall be fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
/s/ Gregory S. Curhan
2024-08-20